Clinical Trials Logo
  1. Home
  2. Cardiogenic Shock
  3. NCT04850248
  4. Details
NCT04850248 Clinical Trial

Scoring Model for Predicting Outcome in Patients With Cardiogenic Shock

Cardiogenic Shock Clinical Trial

Official title:
Scoring Model for Predicting Outcome in Patients With Cardiogenic Shock: From Emergency Room to Intensive Care Unit

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04850248
Other study ID # 202103043RIND
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date July 1, 2021
Est. completion date June 1, 2022

Study information
Verified date April 2021
Source National Taiwan University Hospital
Contact Min-Shan Tsai, MD, PhD
Phone 02-23123456
Email mshanmshan@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to develop a predictive model for the outcomes of patients with cardiogenic shock

Description:

This retrospective observational study will enroll patients with cardiogenic shock admitted to the cardiac care unit. Patient characteristics, clinical events during hospitalization, and laboratory examination findings will be collected and analyzed to determine factors associated with mortality. A nomogram will be developed accordingly and will undergo both internal and external validation.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 999
Est. completion date June 1, 2022
Est. primary completion date June 1, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Patients with cardiogenic shock - Admitted to the cardiac care unit (CCU) Exclusion Criteria: - Non-cardiogenic shock in origin - Post open heart surgery

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• no intervention, this is an observational study
no intervention, this is an observational study

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
National Taiwan University Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary Mortality In-hospital mortality through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT03283995 - Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology
Active, not recruiting NCT04325035 - The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock Phase 2
Active, not recruiting NCT05100836 - SURPASS Impella 5.5 Study
Not yet recruiting NCT05106491 - Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients N/A
Completed NCT02301819 - ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock N/A
Completed NCT01367743 - Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock Phase 4
Recruiting NCT05728359 - Genomic Determinants of Outcome in Cardiogenic Shock
Recruiting NCT05699005 - Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO Phase 1
Not yet recruiting NCT06338345 - Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients N/A
Completed NCT03436641 - Microcirculation in Cardiogenic Shock
Recruiting NCT03313687 - SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Recruiting NCT05506449 - The RECOVER IV Trial N/A
Completed NCT04144660 - "Treatment Use of ECMO In Pregnancy or Peripartum Patient."
Completed NCT04548739 - Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)
Recruiting NCT04141410 - Global Longitudinal Strain Assessment in Cardiogenic Shock During Sepsis
Not yet recruiting NCT05879276 - Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function. Phase 3
Enrolling by invitation NCT05570864 - Score TO Predict SHOCK - STOP SHOCK
Completed NCT02591771 - Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock Phase 2
Terminated NCT02279979 - Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial N/A
Completed NCT01374867 - CardShock Study and Registry N/A